Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CR2 encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Additionally we are shipping Complement Component (3d/Epstein Barr Virus) Receptor 2 Kits (28) and Complement Component (3d/Epstein Barr Virus) Receptor 2 Proteins (15) and many more products for this protein.
Showing 10 out of 502 products:
Cow (Bovine) Monoclonal CR2 Primary Antibody for FACS, IHC (fro) - ABIN238434
Twohig, Kulik, Haluszczak, Reuter, Rossbach, Bull, Holers, Marchbank: Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3. in Molecular immunology 2007
Show all 8 references for 238434
Human Monoclonal CR2 Primary Antibody for IHC (p) - ABIN114419
Nemerow, McNaughton, Cooper: Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes. in Journal of immunology (Baltimore, Md. : 1950) 1985
Show all 3 references for 114419
Human Monoclonal CR2 Primary Antibody for FACS - ABIN4898010
Notley, Brown, Wright, Ehrenstein: Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. in Journal of immunology (Baltimore, Md. : 1950) 2011
Human Monoclonal CR2 Primary Antibody for FACS, IHC (fro) - ABIN119512
Furukawa, Bangham, Taylor, Weber, Osame: Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). in Clinical and experimental immunology 2000
Human Monoclonal CR2 Primary Antibody for FACS - ABIN1106068
Brok, Hornby, Griffiths, Scott, Hart: An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. in Cytometry 2001
Human Monoclonal CR2 Primary Antibody for FACS, IHC (p) - ABIN1106062
Prodinger, Schwendinger, Schoch, Köchle, Larcher, Dierich: Characterization of C3dg binding to a recess formed between short consensus repeats 1 and 2 of complement receptor type 2 (CR2; CD21). in Journal of immunology (Baltimore, Md. : 1950) 1998
Human Polyclonal CR2 Primary Antibody for EIA, FACS - ABIN452871
Rikova, Guo, Zeng, Possemato, Yu, Haack, Nardone, Lee, Reeves, Li, Hu, Tan, Stokes, Sullivan, Mitchell, Wetzel, Macneill, Ren, Yuan, Bakalarski, Villen, Kornhauser, Smith, Li, Zhou, Gygi, Gu et al.: Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. ... in Cell 2007
Binding of PF4 (show PF4 Antibodies)/heparin complexes to B (show TDO2 Antibodies) cells is mediated through the interaction between complement and complement receptor 2.
high pERK (show EIF2AK3 Antibodies) expression and accelerated apoptosis revert within 4 weeks after beginning therapy, whereas clonal B cells unresponsive to TLR9 (show TLR9 Antibodies) stimulation persist for at least 24 weeks, although they may partially rescue normal CD21 expression.
Cerebrospinal fluid (CSF (show CSF2 Antibodies)) soluble complement receptor 2 (sCR2 (show RBMS1 Antibodies)) levels correlated significantly both with CSF (show CSF2 Antibodies) complements C3 and C1q as well as to a disease severity measure.
CR2 contributes to human Osteonecrosis of the femoral head susceptibility in Korean systemic lupus erythematosus patients.
In this study, we have shown that the CR2 +24T>C polymorphism is not a risk marker for nasopharyngeal carcinoma development in the North region of Portugal.
In mature B cells, CD21 transcription proceeds from a focused transcriptional start site regulated by a non-consensus TATA box, an initiator element and a downstream promoter element.
Reduced expression of CD21 on CLL B-cells appears functionally relevant and was associated with poor clinical outcomes.
These data suggest that rs1876453 in CR2 has long-range effects on gene regulation that decrease susceptibility to systemic lupus erythematosus.
repression of the CR2/CD21 promoter can occur through one of the E-box motifs via recruitment of RP58 (show ZNF238 Antibodies).
found that the protective CR2 genotype is correlated with lower levels CR2 mRNA as well as differences in the ratio of the long and short CR2 isoforms
Cattle express two major variants of the Cr2 gene representing homologues of murine CR1 and CR2, each of which is expressed in both a long and a short form.
These results demonstrate that local expression of Cr2 in the central nervous system is part of the axotomy reaction and is suggested to modulate subsequent complement mediated effects.
This study demonistrated that receptors for complement C3 (show C3 Antibodies) fragments (CR2/CR1) may represent a promising future approach for therapeutic immunomodulation after traumatic brain injury.
Data suggest that the Cr2KO mouse thus provides a new model system for the analysis of Cr1 and Cr2 functions in the immune response of the mouse.
Murine B cells predominantly express the Cr2 product from the Cr2 gene, whereas follicular dendritic cells (FDCs) almost exclusively express the Cr1 isoform generated from the Cr2 gene.
immune system uses three different CR1 (show TDGF1 Antibodies)/2-mediated effector functions to generate optimal antibody responses
Absence of CD21/35 protects mice from chronic wasting disease.
We conclude that Cr2 regulates hippocampal neurogenesis
There is a significant reduction in the numbers of both neutrophils and macrophages in cardiac isografts isolated from mice treated with either complement receptor 2-Crry (show CR1L Antibodies) or CR2-factor H (show CFH Antibodies).
Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells.
functionally significant phenotype for the NZM2410 Cr2 allele and strongly support its role as a lupus susceptibility gene
This gene encodes a membrane protein, which functions as a receptor for Epstein-Barr virus (EBV) binding on B and T lymphocytes. Genetic variations in this gene are associated with susceptibility to systemic lupus erythematosus type 9 (SLEB9). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
, complement C3d receptor
, complement receptor type 2
, epstein-Barr virus receptor
, complement component receptor 2
, complement receptor 1 long isoform
, complement receptor 2
, complement receptor type 1
, expressed in B lymphocytes